Wells Fargo & Company Lowers Healthpeak Properties (NYSE:DOC) Price Target to $18.00

Healthpeak Properties (NYSE:DOC) had its price objective dropped by research analysts at Wells Fargo & Company from $19.00 to $18.00 in a research report issued on Monday, MarketBeat.com reports. The firm currently has an “equal weight” rating on the real estate investment trust’s stock. Wells Fargo & Company‘s price target points to a potential upside of 9.32% from the stock’s current price.

Several other analysts have also weighed in on the stock. The Goldman Sachs Group initiated coverage on shares of Healthpeak Properties in a report on Friday, January 9th. They set a “neutral” rating and a $17.00 price objective for the company. Weiss Ratings raised Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 26th. Cantor Fitzgerald set a $17.00 target price on Healthpeak Properties in a research note on Monday, January 5th. Jefferies Financial Group downgraded shares of Healthpeak Properties from a “buy” rating to a “hold” rating and reduced their price target for the stock from $21.00 to $17.00 in a research report on Monday, December 15th. Finally, Evercore ISI lowered their price objective on shares of Healthpeak Properties from $22.00 to $21.00 and set an “outperform” rating for the company in a research report on Monday, December 15th. Seven equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $19.58.

Healthpeak Properties Stock Performance

NYSE DOC opened at $16.47 on Monday. Healthpeak Properties has a twelve month low of $15.71 and a twelve month high of $21.28. The stock has a market cap of $11.44 billion, a P/E ratio of 164.67, a PEG ratio of 4.26 and a beta of 1.12. The company’s 50-day simple moving average is $16.95 and its 200 day simple moving average is $17.62. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 1.11.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 EPS for the quarter, topping the consensus estimate of $0.45 by $0.02. Healthpeak Properties had a return on equity of 0.83% and a net margin of 2.52%.The business had revenue of $719.40 million during the quarter, compared to the consensus estimate of $685.14 million. During the same quarter last year, the company earned $0.46 EPS. Healthpeak Properties’s revenue was up 3.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. As a group, research analysts forecast that Healthpeak Properties will post 1.86 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. JPMorgan Chase & Co. lifted its stake in Healthpeak Properties by 41.0% in the third quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock valued at $540,730,000 after buying an additional 8,212,504 shares during the period. Norges Bank acquired a new stake in shares of Healthpeak Properties in the 2nd quarter valued at approximately $140,558,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Healthpeak Properties by 694.6% during the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock worth $153,520,000 after acquiring an additional 7,007,777 shares during the last quarter. Nordea Investment Management AB grew its holdings in Healthpeak Properties by 7,444.0% during the second quarter. Nordea Investment Management AB now owns 3,923,205 shares of the real estate investment trust’s stock valued at $67,871,000 after purchasing an additional 3,871,201 shares during the period. Finally, Equity Investment Corp grew its holdings in Healthpeak Properties by 209.6% during the third quarter. Equity Investment Corp now owns 5,330,948 shares of the real estate investment trust’s stock valued at $102,088,000 after purchasing an additional 3,608,849 shares during the period. 93.57% of the stock is currently owned by institutional investors.

Key Headlines Impacting Healthpeak Properties

Here are the key news stories impacting Healthpeak Properties this week:

• Positive Sentiment: Q4 operational beat — Healthpeak reported FFO/FFO‑per‑share and revenue that exceeded estimates, supported by same‑store NOI growth across key portfolios; that validates near‑term cash flow resilience. Healthpeak Q4 FFO Beats Estimates, Same-Store NOI Rises Y/Y
• Positive Sentiment: Upgraded FY‑2026 guidance — management set EPS guidance of $1.700–$1.740, materially above consensus, signaling management confidence in cash flow trajectory and the benefit of portfolio reshaping. Healthpeak Provides Strategic Initiatives Update and Reports Q4 2025 Results
• Positive Sentiment: Value‑unlocking moves — Healthpeak outlined strategic initiatives including the planned IPO of Janus Living (a senior‑housing REIT) and portfolio pruning that could crystallize value and focus cash‑flow growth on healthcare real estate. Q4 2025 Earnings Call Transcript
• Neutral Sentiment: REIT sector context — Analysts and outlets still highlight DOC as an attractive healthcare REIT in a stable‑rate backdrop and note a high dividend yield, which supports longer‑term investor interest even if near‑term volatility persists. 2 REITs That Look Attractive in a Stable Rate Environment
• Neutral Sentiment: Third‑party reviews — recent financial writeups and reviews reiterate DOC’s mixed profile (durable demand in healthcare assets but sensitivity to capital markets), which may encourage repositioning by investors. Healthpeak & Americold Financial Review
• Negative Sentiment: Analyst target cut — Wells Fargo trimmed its price target and maintained an “equal weight” stance, which can prompt short‑term selling and reduce upside conviction among institutional holders. DOC Price Target Lowered at Wells Fargo
• Negative Sentiment: GAAP profitability and leverage concerns — the company still shows negative GAAP net margin and low ROE on recent reporting, plus meaningful leverage (debt/equity ~1.11), which keeps some investors cautious about valuation and balance‑sheet risk. MarketBeat Earnings Summary and Press Release

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.